Gabriele Magarò

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors

Noemi D’Atanasio, Alessandra Capezzone de Joannon, Laura Di Sante et al. · PLoS ONE · 2020 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Hit Optimization of 5-Substituted-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders

Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla et al. · Journal of Medicinal Chemistry · 2015 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery and Pharmacological Profile of New 1<i>H</i>-Indazole-3-carboxamide and 2<i>H</i>-Pyrrolo[3,4-<i>c</i>]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands

Guido Furlotti, Maria Alessandra Alisi, Claudia Apicella et al. · Journal of Medicinal Chemistry · 2012 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Virtual Screening Approach and Investigation of Structure–Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens

Gabriele Magarò, Federica Prati, Barbara Garofalo et al. · Journal of Medicinal Chemistry · 2019 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Targeting Serotonin 2A and Adrenergic α₁ Receptors for Ocular Antihypertensive Agents: Discovery of 3,4‐Dihydropyrazino[1,2‐<i>b</i>]indazol‐1(2<i>H</i>)‐one Derivatives

Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla et al. · ChemMedChem · 2018 · 15 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13